文献速递肾移植

死者供肾移植后第一年延迟恢复功能与无延迟恢复功能患者间质纤维化进展比较

Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function.
PubMed 文献 · Clin J Am Soc Nephrol · 2016-10-24

该回顾性研究纳入2003年7月至2014年9月本中心所有死者供肾移植患者,比较延迟恢复功能组与非延迟恢复功能组移植后第一年间质纤维化进展。结果显示两组Δ纤维化分布相似(P=0.91),纤维化进展斜率亦相似(P=0.66);供者来源纤维化可能增加延迟恢复功能风险(OR 1.70,95%CI 1.03-2.82)。

要点

  • 供者来源纤维化可能增加延迟恢复功能风险(OR 1.70,95%CI 1.03-2.82)。
  • 延迟恢复功能组与非延迟恢复功能组Δ纤维化分布相似(P=0.91)。
  • 两组纤维化进展斜率相似(P=0.66),延迟恢复功能似乎不增加第一年纤维化进展。

核心结论

  • 供者来源纤维化可能增加延迟恢复功能风险,但延迟恢复功能似乎不增加移植后第一年纤维化进展。

研究设计与样本

  • 回顾性研究,纳入2003年7月至2014年9月本中心所有死者供肾移植患者。
  • 延迟恢复功能组343例(36.7%),对照组591例。
  • 主要结局为移植后第一年系列方案活检中间质纤维化进展。

主要发现

  • 延迟恢复功能组与非延迟恢复功能组0月活检率分别为65.3%(n=224)和67.0%(n=396),12月分别为64.4%(n=221)和68.4%(n=404)。
  • 配对活检在延迟恢复功能组155例、对照组283例中可用。
  • 风险校正模型中,0月活检Banff ci评分>0与延迟恢复功能风险升高相关(OR 1.70,95%CI 1.03-2.82)。
  • 0至12月Δ纤维化分布在延迟恢复功能组与对照组相似(P=0.91)。
  • 纤维化进展斜率在两组间亦相似(P=0.66)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Delayed graft function is a form of AKI resulting from ischemia-reperfusion injury. Our aim was to study the effect of delayed graft function on the progression of interstitial fibrosis after deceased donor kidney transplantation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our study is a retrospective study of all patients transplanted at our center between July of 2003 and September of 2014 using a kidney from a deceased donor. The primary outcome was the progression of interstitial fibrosis on serial protocol biopsies done during the first year post-transplant. We analyzed the distribution of the change in the Banff interstitial fibrosis (ci) score between the delayed graft function and nondelayed graft function groups for all of the paired biopsies done at time 0 and 12 months post-transplant (Δfibrosis). We also performed a linear mixed model analyzing the difference in the slopes for the progression of mean Banff ci score for all of the biopsies done at time 0 and 1, 4, and 12 months post-transplant. RESULTS: There were 343 (36.7%) in the delayed graft function group and 591 in the control group. The biopsy rates for the delayed graft function and nondelayed graft function groups at time 0 were 65.3% (n=224) and 67.0% (n=396), respectively, and at 12 months, they were 64.4% (n=221) and 68.4% (n=404), respectively. Paired biopsies were available for 155 in the delayed graft function group and 283 in the control group. In a risk-adjusted model, Banff ci score >0 on the time 0 biopsy had a higher odds of delayed graft function (odds ratio, 1.70; 95% confidence interval, 1.03 to 2.82). The distribution of the Δfibrosis between 0 and 12 months was similar in delayed graft function and control groups (P=0.91). The slopes representing the progression of fibrosis were also similar between the groups (P=0.66). CONCLUSIONS: Donor-derived fibrosis may increase the odds of delayed graft function; however, delayed graft function does not seem to increase the progression of fibrosis during the first year after transplantation.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Heilman RL, Smith ML, Smith BH, et al. Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function. Clin J Am Soc Nephrol. 2016. PMID: 27797897. doi:10.2215/CJN.05060516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。